Advertisement
Skip to Content

Kuros Biosciences Ltd CSBTF Stock Quote

| Rating as of

PINX: CSBTF

Last close prices updated as of May 10, 2022, 2:35 PM EST | USD
  • Last Close 1.92
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Blend
  • Day Range 1.92  –  1.92
  • Year Range 1.92  –  3.10
  • Market Cap 62.9647 Mil
  • Volume / Avg 7,900.0 /  5,900.0
  • Price / Sales 4.35
  • Price / Book 0.78
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis CSBTF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CSBTF

Company Profile CSBTF

Business Description

Kuros Biosciences Ltd is a biotechnology company that focuses on the discovery, development and prospective commercialization of a new class of bio-pharmaceutical products for use in the treatment and prevention of chronic diseases. The company is also developing a family of bone healing products to address indications in trauma, and spine as well as sealants which provides reliable closure of tissue membranes to ensure functional integrity after surgery or trauma. The pipeline products of the company are Synthetic Orthobiologics, Fibrin Orthobiologics, and Sealants. The majority of the company's revenue comes from the United States.

Contact
Wagistrasse 25
Schlieren, 8952, CHE
Industry Biotechnology
Employees 58

FAQs for Kuros Biosciences Ltd Stock

No. CSBTF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CSBTF’s market cap is 62.96 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CSBTF’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CSBTF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CSBTF’s historical performance against its industry peers and the overall market.